A phase II trial of bevacizumab-GemAOD regimen for newly diagnosed extranodal NK/T cell lymphoma

Autor:	Tian Xiao Gao, Zhi Ming Li, Peng Sun, Suxia Lin, Wenqi Jiang, Ke Wu, Hanyu Wang, Yi Xia, Jia Jia Huang, Fan Feng, Panpan Liu, Yu Wang, Huilan Rao, Xiwen Bi
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy Bevacizumab business.industry medicine.medical_treatment Newly diagnosed medicine.disease Targeted therapy Lymphoma Regimen Internal medicine medicine T-cell lymphoma business medicine.drug
Zdroj:	Journal of Clinical Oncology. 36:7564-7564
ISSN:	1527-7755 0732-183X
Popis:	7564Background: Efficacy of L-asparaginase-based regimens has been confirmed for patients with extranodal natural killer/T-cell lymphoma (ENKTL). However, targeted therapy and optimal chemotherapy ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::68aa44247745bf68a4331e770f07fdce https://doi.org/10.1200/jco.2018.36.15_suppl.7564 Zobrazit plný text záznamu